Advertisement
Screener

Canopy Growth Corp (CGC) Payments to Acquire Other Productive Assets

2.0 / 5 stars · 16/40 Roast Me

Canopy Growth Corp Payments to Acquire Other Productive Assets

Canopy Growth Corp (CGC) reported Payments to Acquire Other Productive Assets of CAD 29.20 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireOtherProductiveAssets · last filed 2022-08-09

  • Canopy Growth Corp payments to acquire other productive assets for the quarter ending 2022-06-30 was 29.20M CAD.
  • Canopy Growth Corp payments to acquire other productive assets for the quarter ending 2022-03-31 was 5.00M CAD, a 52.31% decline year-over-year.
  • Canopy Growth Corp payments to acquire other productive assets for the quarter ending 2021-03-31 was 10.48M CAD, a 87.36% decline year-over-year.
  • Canopy Growth Corp payments to acquire other productive assets for the quarter ending 2020-12-31 was 26.71M CAD, a 161.25% increase year-over-year.
  • Canopy Growth Corp payments to acquire other productive assets for fiscal 2022 was 379.41M CAD, a 748.40% increase from fiscal 2021.
  • Canopy Growth Corp payments to acquire other productive assets for fiscal 2021 was 44.72M CAD, a 65.49% decline from fiscal 2020.
  • Canopy Growth Corp payments to acquire other productive assets for fiscal 2020 was 129.59M CAD, a 41.88% increase from fiscal 2019.
  • Canopy Growth Corp payments to acquire other productive assets for fiscal 2019 was 91.34M CAD, a 307.05% increase from fiscal 2018.
Period endPayments to Acquire Other Productive Assets 3 monthPayments to Acquire Other Productive Assets 6 monthPayments to Acquire Other Productive Assets 9 monthPayments to Acquire Other Productive Assets 12 month
2022-06-3029.20M CAD
10-Q · filed 2022-08-09
34.20M CAD
derived: sum of 2 quarters · filed 2022-08-09
2022-03-315.00M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
379.41M CAD
10-K · filed 2022-05-31
2021-12-31374.41M CAD
10-Q · filed 2022-02-09
2021-03-3110.48M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
37.20M CAD
derived: sum of 2 quarters · filed 2022-05-31
42.16M CAD
derived: sum of 3 quarters · filed 2022-05-31
44.72M CAD
10-K · filed 2022-05-31
2020-12-3126.71M CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09
31.67M CAD
derived: sum of 2 quarters · filed 2022-02-09
34.24M CAD
10-Q · filed 2022-02-09
117.18M CAD
derived: sum of 4 quarters · filed 2022-05-31
2020-09-304.96M CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-09
7.53M CAD
10-Q · filed 2020-11-09
90.47M CAD
derived: sum of 3 quarters · filed 2022-05-31
100.69M CAD
derived: sum of 4 quarters · filed 2022-05-31
2020-06-302.56M CAD
10-Q · filed 2020-08-10
85.51M CAD
derived: sum of 2 quarters · filed 2022-05-31
95.73M CAD
derived: sum of 3 quarters · filed 2022-05-31
102.74M CAD
derived: sum of 4 quarters · filed 2022-05-31
2020-03-3182.94M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
93.17M CAD
derived: sum of 2 quarters · filed 2022-05-31
100.18M CAD
derived: sum of 3 quarters · filed 2022-05-31
129.59M CAD
10-K · filed 2022-05-31
2019-12-3110.22M CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09
17.23M CAD
derived: sum of 2 quarters · filed 2021-02-09
46.65M CAD
10-Q · filed 2021-02-09
2019-09-307.01M CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-09
36.42M CAD
10-Q · filed 2020-11-09
2019-06-3029.41M CAD
10-Q · filed 2020-08-10
2019-03-3191.34M CAD
10-K · filed 2021-06-01
2018-03-3122.44M CAD
10-K · filed 2020-06-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87